4-Mar-2025
BeautyHealth to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
Globe Newswire (Tue, 4-Mar 4:05 PM ET)
Beauty Health Announces New Executive Appointments
TipRanks (Fri, 28-Feb 4:48 PM ET)
Business Wire (Thu, 20-Feb 3:18 PM ET)
BeautyHealth Appoints Stephen J. Fanning to Board of Directors
Business Wire (Tue, 17-Dec 4:30 PM ET)
BeautyHealth Releases 2024 Skintuition Report
Business Wire (Wed, 11-Dec 8:00 AM ET)
Business Wire (Fri, 6-Dec 9:30 AM ET)
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets, and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.
Beauty Health Company - Class A trades on the NASDAQ stock market under the symbol SKIN.
As of March 4, 2025, SKIN stock price declined to $1.16 with 1,992,997 million shares trading.
SKIN has a beta of 3.01, meaning it tends to be more sensitive to market movements. SKIN has a correlation of 0.24 to the broad based SPY ETF.
SKIN has a market cap of $143.86 million. This is considered a Micro Cap stock.
Last quarter Beauty Health Company - Class A reported $79 million in Revenue and -$.15 earnings per share. This beat revenue expectation by $5 million and missed earnings estimates by -$.03.
In the last 3 years, SKIN traded as high as $19.38 and as low as $.91.
The top ETF exchange traded funds that SKIN belongs to (by Net Assets): VTI, IWM, VXF, VDC, IWO.
SKIN has underperformed the market in the last year with a price return of -68.2% while the SPY ETF gained +14.0%. SKIN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -21.1% and -29.7%, respectively, while the SPY returned -4.7% and -5.7%, respectively.
SKIN support price is $1.21 and resistance is $1.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SKIN shares will trade within this expected range on the day.